Home › Employers › Immunome, Inc.
Immunome, Inc.: H-1B salaries and sponsorship
Immunome, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $245,036.
Does Immunome, Inc. sponsor H-1B visas?
Immunome, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 3, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Executive Director, Clinical Development | 2 | $292,536 |
| Sr. Director, CMC Technical Lead for Varegacestat | 1 | $211,994 |
| Varegacestat Brand Lead | 1 | $275,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 1 | $211,994 |
| FY2026 | 3 | $275,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Executive Director, Clinical Development | $215,072 Level IV | Bothell, WA | Jun 3, 2026 | Oct 1, 2026 | Certified |
| Varegacestat Brand Lead | $275,000 Level IV | Bothell, WA | May 5, 2026 | Oct 1, 2026 | Certified |
| Executive Director, Clinical Development | $370,000 Level IV | Bothell, WA | Apr 28, 2026 | Oct 1, 2026 | Certified |
| Sr. Director, CMC Technical Lead for Varegacestat | $211,994–$351,000 Level III | Bothell, WA | Jun 12, 2025 | Oct 1, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).